DOCSLIB.ORG

Estrone-3-Glucuronide ELISA Kit

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Estrone-3-Glucuronide ELISA Kit Estrone-3-Glucuronide ELISA Kit Item No. 501290 www.caymanchem.com Customer Service 800.364.9897 Technical Support 888.526.5351 1180 E. Ellsworth Rd · Ann Arbor, MI · USA TABLE OF CONTENTS GENERAL INFORMATION GENERAL INFORMATION 3 Materials Supplied Materials Supplied 4 Safety Data 4 Precautions 5 If You Have Problems Item Number Item 96 wells Quantity/Size 5 Storage and Stability 5 Materials Needed but Not Supplied 501291 Estrone-3-Glucuronide ELISA Antiserum 1 vial/100 dtn INTRODUCTION 6 Background 501292 Estrone-3-Glucuronide AP Tracer 1 vial/100 dtn 6 About This Assay 501293 Estrone-3-Glucuronide ELISA Standard 1 vial 7 Principle of Assay 8 Definition of Key Terms 400080 Tris Buffer Concentrate (10X) 1 vial/10 ml PRE-ASSAY PREPARATION 10 Buffer Preparation 411007 AP Wash Buffer Concentrate (150X) 1 vial/5 ml 11 Sample Preparation 400004/400006 Mouse Anti-Rabbit IgG Coated Plate 1 plate ASSAY PROTOCOL 16 Preparation of Assay-Specific Reagents 400089 pNPP Substrate Solution 2 vials/12 ml 18 Plate Set Up 19 Performing the Assay 400040 ELISA Tracer Dye 1 ea ANALYSIS 21 Calculations 400042 ELISA Antiserum Dye 1 ea 22 Performance Characteristics 400012 96-Well Cover Sheet 1 cover 30 Assay Summary 31 Plate Template RESOURCES 32 Troubleshooting If any of the items listed above are damaged or missing, please contact our Customer Service department at (800) 364-9897 or (734) 971-3335. We cannot 33 References accept any returns without prior authorization. 34 Notes GENERAL INFORMATION 3 If You Have Problems WARNING: THIS PRODUCT IS FOR RESEARCH ONLY - NOT FOR HUMAN OR VETERINARY DIAGNOSTIC OR THERAPEUTIC USE. Technical Service Contact Information ! Phone: 888-526-5351 (USA and Canada only) or 734-975-3888 Safety Data Fax: 734-971-3640 Email: [email protected] This material should be considered hazardous until further information becomes In order for our staff to assist you quickly and efficiently, please be ready to supply available. Do not ingest, inhale, get in eyes, on skin, or on clothing. Wash the lot number of the kit (found on the outside of the box). thoroughly after handling. Before use, the user must review the complete Safety Data Sheet, which has been sent via email to your institution. Storage and Stability Precautions This kit will perform as specified if stored as directed at -20°C and used before the expiration date indicated on the outside of the box. Please read these instructions carefully before beginning this assay. This kit may not perform as described if any reagent or procedure is replaced or Materials Needed But Not Supplied modified. When compared to quantification by LC/MS or GC/MS, it is not uncommon 1. A plate reader capable of measuring absorbance at 405 nm. for immunoassays to report higher analyte concentrations. While LC/MS or 2. Adjustable pipettes and a repeating pipettor. GC/MS analyses typically measure only a single compound, antibodies used 3. A source of pure water; glass distilled water or deionized water is acceptable. in immunoassays sometimes recognize not only the target molecule, but also NOTE: Ultra-Pure water is available for purchase from Cayman (Item No. structurally related molecules, including biologically relevant metabolites. In 400000). many cases, measurement of both the parent molecule and metabolites is more representative of the overall biological response than is the measurement of a 4. Materials used for Sample Preparation (see page 11). short-lived parent molecule. It is the responsibility of the researcher to understand the limits of both assay systems and to interpret their data accordingly. 4 GENERAL INFORMATION GENERAL INFORMATION 5 INTRODUCTION Principle of the Assay This assay is based on the competition between estrone-3-glucuronide and Background an estrone-3-glucuronide-alkaline phosphatase (AP) conjugate (Estrone-3- Glucuronide AP Tracer) for a limited amount of Estrone-3-Glucuronide ELISA Estrone-3-glucuronide is the predominant metabolite of estradiol in urine and Antiserum. Because the concentration of the Estrone-3-Glucuronide AP Tracer a urinary marker for the fertile window in women.1 Measurement of urinary is held constant while the concentration of estrone-3-glucuronide standards and glucuronides is a convenient, non-invasive method for detecting reproductive samples vary, the amount of Estrone-3-Glucuronide AP Tracer that is able to bind hormone levels compared to measuring plasma levels.2 Estrone-3-glucuronide, to the Estrone-3-Glucuronide ELISA Antiserum will be inversely proportional to along with pregnanediol-3-glucuronide, are indicators of female reproductive the concentration of estrone-3-glucuronide in the well. This antibody-estrone-3- health.2 glucuronide complex binds to a mouse anti-rabbit IgG that has been previously Literature has shown high plasma estrone levels, which directly correlate to attached to the well. The plate is washed to remove any unbound reagents and urinary estrone-3-glucuronide levels, are associated with estrogen receptor- then pNPP Substrate Solution is added to the well. The product of this enzymatic 3 positive breast cancers. Hormone receptor status is the main factor in planning reaction has a distinct yellow color and absorbs strongly at 405 nm. The intensity treatment and can be treated with hormone therapies, including tamoxifen and of this color, determined spectrophotometrically, is proportional to the amount aromatase inhibitors. In addition to its role in breast cancer, circulating estrogens, of Estrone-3-Glucuronide AP Tracer bound to the well, which is inversely including estrone metabolized from oral hormone replacement therapy, have proportional to the amount of free estrone-3-glucuronide present in the well been shown to increase thrombin generation leading to higher risk for blood during the incubation; or clots, myocardial infarctions, deep vein thrombosis and strokes.4-6 Absorbance ∝ [Bound Estrone-3-Glucuronide AP Tracer] ∝ 1/[Estrone-3-Glucuronide] About This Assay A schematic of this process is shown in Figure 1, on page 8 Cayman’s Estrone-3-Glucuronide ELISA Kit is a competitive assay that can be used for quantification of estrone metabolites in urine, plasma and serum. This assay has a range from 2.7-6,000 pg/ml with a midpoint of approximately 125.6 pg/ml (50% B/B0) and a sensitivity of approximately 23.2 pg/ml (80% B/B0). 6 INTRODUCTION INTRODUCTION 7 Standard Curve: a plot of the %B/B0 values versus concentration of a series of wells containing various known amounts of analyte. Dtn: determination, where one dtn is the amount of reagent used per well. Cross Reactivity: numerical representation of the relative reactivity of this assay Wells are pre-coated with 1. Incubate with tracer, = Mouse Anǎ-Rabbit IgG mouse anǎ-rabbit IgG and anǎbody, and either towards structurally related molecules as compared to the primary analyte of interest. blocked with a proprietary standard or sample. = Blocking proteins formulaǎon of proteins. Biomolecules that possess similar epitopes to the analyte can compete with the = Alkaline Phosphatase linked to Estrone-3-Glucuronide (tracer) assay tracer for binding to the primary antibody. Substances that are superior to the = Specific anǎbody to Estrone-3-Glucuronide analyte in displacing the tracer result in a cross reactivity that is greater than 100%. = Free Estrone-3-Glucuronide Substances that are inferior to the primary analyte in displacing the tracer result in a cross reactivity that is less than 100%. Cross reactivity is calculated by comparing the mid-point (50% B/B ) value of the tested molecule to the mid-point (50% B/B ) 2. Wash to remove all 3. Develop the well with 0 0 unbound reagents. pNPP soluǎon. value of the primary analyte when each is measured in assay buffer using the following formula: 50% B/B value for the primary analyte Figure 1. Schematic of the ELISA % Cross Reactivity = 0 x 100% [ 50% B/B0 value for the potential cross reactant ] Definition of Key Terms Lower Limit of Detection (LLOD): the smallest measure that can be detected with Blank: background absorbance caused by pNPP Substrate Solution. The blank reasonable certainty for a given analytical procedure. The LLOD is defined as a point, absorbance should be subtracted from the absorbance readings of all the other wells. two standard deviations away from the mean zero value. Total Activity (TA): total enzymatic activity of the alkaline phosphatase-linked tracer. NSB (Non-Specific Binding): non-immunological binding of the tracer to the well. Even in the absence of specific antibody a very small amount of tracer still binds to the well; the NSB is a measure of this low binding. B0 (Maximum Binding): maximum amount of the tracer that the antibody can bind in the absence of free analyte. %B/B0 (%Bound/Maximum Bound): ratio of the absorbance of a particular sample or standard well to that of the maximum binding (B0) well. 8 INTRODUCTION INTRODUCTION 9 PRE-ASSAY PREPARATION Sample Preparation This assay has been demonstrated to work with urine, human plasma and human Buffer Preparation serum without extraction. Proper sample storage and preparation are essential for consistent and accurate results. Please read this section thoroughly before Store all diluted buffers at 4°C; they will be stable for about two months. beginning the assay. 1. Tris Buffer Preparation General Precautions Dilute the contents of one vial of Tris Buffer Concentrate (10X) (Item No. • All samples must be free of organic solvents prior to assay. 400080) with 90 ml of Pure Water. Be certain to rinse the vial to remove • Samples should be assayed immediately after collection; samples that any salts that may have precipitated. NOTE: It is normal for the concentrated cannot be assayed immediately should be stored at -80°C. buffer to contain crystalline salts after thawing. These will completely dissolve • Samples of rabbit origin may contain antibodies which interfere with the upon dilution with water.
Load more

Recommended publications
  • United States July 2016 2 Table of Contents
    Deuterium Labelled Compounds United States July 2016 2 Table of Contents International Distributors 3 Corporate Overview 4 General Information 5 Pricing and Payment 5 Quotations 5 Custom Synthesis 5 Shipping 5 Quality Control 6 Quotations 6 Custom Synthesis 6 Shipping 6 Quality Control 6 Chemical Abstract Service Numbers 6 Handling Hazardous Compounds 6 Our Products are Not Intended for Use in Humans 7 Limited Warranty 7 Packaging Information 7 Alphabetical Listings 8 Stock Clearance 236 Products by Category 242 n-Alkanes 243 α-Amino Acids, N-Acyl α-Amino Acids, N-t-BOC Protected α-Amino Acid 243 and N-FMOC Protected α-Amino Acids Buffers and Reagents for NMR Studies 245 Detergents 245 Environmental Standards 246 Fatty Acids and Fatty Acid Esters 249 Flavours and Fragrances 250 Gases 253 Medical Research Products 254 Nucleic Acid Bases and Nucleosides 255 Pesticides and Pesticide Metabolites 256 Pharmaceutical Standards 257 Polyaromatic Hydrocarbons (PAHs), Alkyl-PAHs, Amino-PAHs, 260 Hydroxy-PAHs and Nitro-PAHs Polychlorinated Biphenyls (PCBs) 260 Spin Labels 261 Steroids 261 3 International Distributors C Beijng Zhenxiang H EQ Laboratories GmbH Australia K Technology Company Graf-von-Seyssel-Str. 10 Rm. 15A01, Changyin Bld. 86199 Augsburg Austria H No. 88, YongDingLu Rd. Germany Beijing 100039 Tel.: (49) 821 71058246 Belgium J China Fax: (49) 821 71058247 Tel.: (86) 10-58896805 [email protected] China C Fax: (86) 10-58896158 www.eqlabs.de Czech Republic H [email protected] Germany, Austria, China Czech Republic, Greece, Denmark I Hungary,
    [Show full text]
  • C:\Data\Ndaenjuvia\AP LTR 05-07-04
    NDA 21-443 Package Insert ENJUVIA™ (synthetic conjugated estrogens, B) Tablets Rx only ESTROGENS INCREASE THE RISK OF ENDOMETRIAL CANCER Close clinical surveillance of all women taking estrogens is important. Adequate diagnostic measures, including endometrial sampling when indicated, should be undertaken to rule out malignancy in all cases of undiagnosed persistent or recurring abnormal vaginal bleeding. There is no evidence that the use of “natural” estrogens results in a different endometrial risk profile than synthetic estrogens at equivalent estrogen doses. (See WARNINGS, Malignant neoplasms, Endometrial cancer.) CARDIOVASCULAR AND OTHER RISKS Estrogens with or without progestins should not be used for the prevention of cardiovascular disease. (See WARNINGS, Cardiovascular disorders.) The Women’s Health Initiative (WHI) study reported increased risks of myocardial infarction, stroke, invasive breast cancer, pulmonary emboli, and deep vein thrombosis in postmenopausal women (50 to 79 years of age) during 5 years of treatment with oral conjugated estrogens (CE 0.625 mg) combined with medroxyprogesterone acetate (MPA 2.5 mg) relative to placebo. (See CLINICAL PHARMACOLOGY, Clinical Studies). The Women’s Health Initiative Memory Study (WHIMS), a substudy of WHI, reported increased risk of developing probable dementia in postmenopausal women 65 years of age or older during 4 years of treatment with oral conjugated estrogens plus medroxyprogesterone acetate relative to placebo. It is unknown whether this finding applies to younger postmenopausal women or to women taking estrogen alone therapy. (See CLINICAL PHARMACOLOGY, Clinical Studies.) Other doses of oral conjugated estrogens with medroxyprogesterone acetate, and other combinations and dosage forms of estrogens and progestins were not studied in the WHI clinical trials and, in the absence of comparable data, these risks should be assumed to be similar.
    [Show full text]
  • Excretion Patterns of Fecal Progestagens, Androgen and Estrogens During Pregnancy, Parturition and Postpartum in Okapi (Okapia Johnstoni)
    Journal of Reproduction and Development, Vol. 53, No. 1, 2007 —Research Note— Excretion Patterns of Fecal Progestagens, Androgen and Estrogens During Pregnancy, Parturition and Postpartum in Okapi (Okapia johnstoni) Satoshi KUSUDA1), Koki MORIKAKU2), Ken-ichi KAWADA3), Kenji ISHIWADA4)# and Osamu DOI3) 1)Laboratory of Animal Reproduction, United Graduate School of Agricultural Science, Gifu University, Gifu 501-1193, 2)Preservation and Research Center, City of Yokohama, Kanagawa 241-0804, 3)Laboratory of Animal Reproduction, Faculty of Applied Biological Sciences, Gifu University, Gifu 501-1193 and 4)Yokohama Zoological Gardens Zoorasia, Kanagawa 241- 0001, Japan #Present: Kanazawa Zoological Gardens of Yokohama, Kanagawa 236-0042, Japan Abstract. The aim of the present study was to establish a simple method to monitor ovarian activity and non-invasively diagnose pregnancy in okapi (Okapia johnstoni). The feces of a female okapi were collected daily or every 3 days for 28 months. Steroids in lyophilized feces were extracted with 80% methanol, and the fecal levels of immunoreactive progestagens (progesterone and pregnanediol- glucuronide), androgen (testosterone), and estrogens (estradiol-17β and estrone) were determined by enzyme immunoassays with commercially available antisera. Using the progesterone profiles, the durations of the luteal phase, follicular phase, and estrous cycle were determined to be 11.1 ± 0.4, 5.3 ± 0.6, and 16.5 ± 0.7 days (n=22), respectively. Fecal levels of immunoreactive progesterone, pregnanediol glucuronide, and testosterone gradually increased from early pregnancy and peaked several months before parturition. More pregnanediol glucuronide was excreted in feces than progesterone during late pregnancy, but not during the estrous cycle. Although the fecal concentrations of immunoreactive estradiol-17β and estrone change a little throughout pregnancy and non-pregnancy, they rose sharply and temporarily on the day following parturition.
    [Show full text]
  • Estrone Sulfate
    Available online at www.sciencedirect.com Journal of Steroid Biochemistry & Molecular Biology 109 (2008) 158–167 Estrone sulfate (E1S), a prognosis marker for tumor aggressiveness in prostate cancer (PCa)ଝ Frank Giton a,∗, Alexandre de la Taille b, Yves Allory b, Herve´ Galons c, Francis Vacherot b, Pascale Soyeux b, Claude Clement´ Abbou b, Sylvain Loric b, Olivier Cussenot b, Jean-Pierre Raynaud d, Jean Fiet b a AP-HP CIB INSERM IMRB U841eq07, Henri Mondor, Facult´edeM´edecine, 94010 Cr´eteil, France b INSERM IMRB U841 eq07, CHU Henri Mondor, Facult´edeM´edecine, 94010 Cr´eteil, France c Service de Chimie organique, Facult´e de Pharmacie Paris V, 75006 Paris, France d Universit´e Pierre et Marie Curie, 75252 Paris, France Received 26 December 2006; accepted 26 October 2007 Abstract Seeking insight into the possible role of estrogens in prostate cancer (PCa) evolution, we assayed serum E2, estrone (E1), and estrone sulfate (E1S) in 349 PCa and 100 benign prostatic hyperplasia (BPH) patients, and in 208 control subjects in the same age range (50–74 years). E1 (pmol/L ± S.D.) and E1S (nmol/L ± S.D.) in the PCa and BPH patients (respectively 126.1 ± 66.1 and 2.82 ± 1.78, and 127.8 ± 56.4 and 2.78 ± 2.12) were significantly higher than in the controls (113.8 ± 47.6 and 2.11 ± 0.96). E2 was not significantly different among the PCa, BPH, and control groups. These assays were also carried out in PCa patients after partition by prognosis (PSA, Gleason score (GS), histological stage, and surgical margins (SM)).
    [Show full text]
  • 01 Front.Pdf
    Copyright is owned by the Author of the thesis. Permission is given for a copy to be downloaded by an individual for the purpose of research and private study only. The thesis may not be reproduced elsewhere without the permission of the Author. STUDIES TOWARDS THE DEVELOPMENT OF A MULTI­ PURPOSE HOME SELF-TEST KIT FOR THE DETECTION OF URINARY TETRAHYDROCORTISONE AND TESTOSTERONE METABOLITES A thesis submitted in partial fulfilment of the requirements for the degree of Master of Science in Chemistry at Massey University Claire Margaret Nielsen 2003 ii Abstract The development of homogeneous enzyme immunoassays (HEIA) for testosterone glucuronide (TG) and tetrahydrocortisone glucuronide (THEG) in urine are described. The proposed test system is based on the Ovarian Monitor homogeneous immunoassay system, established by J.B Brown and L.F. Blackwell et al. 1 as a simple, laboratory accurate, monitoring device for the measurement of estrone glucuronide (E1G) and pregnanediol glucuronide (PdG) as markers of the fertile phase during a womans menstrual cycle. This information can be used readily by women to identify their cyclical periods of fertility and infertility. The major testosterone metabolite in the urine of males, testosterone p-glucuronide, was synthesised by firstly preparing the glycosyl donor a-bromosugar and conjugating this with testosterone under standard Koenigs-Knorr conditions. 1H nmr studies confirmed that the synthetic steroid glucuronide had the same stereochemistry as the naturally occurring urinary testosterone glucuronide. Testosterone glucuronide and tetrahydrocortisone glucuronide conjugates of hen egg white lysozyme were prepared using the active ester coupling method in good yield. Unreacted lysozyme was successfully removed from the reaction mixture by a combination of cation­ exchange chromatography in 7 M urea and hydrophobic-interaction chromatography.
    [Show full text]
  • Steroid Profiling in Urine of Intact Glucuronidated and Sulfated
    CORE Metadata, citation and similar papers at core.ac.uk Provided by Ghent University Academic Bibliography Journal of Chromatography A 1624 (2020) 461231 Contents lists available at ScienceDirect Journal of Chromatography A journal homepage: www.elsevier.com/locate/chroma Steroid profiling in urine of intact glucuronidated and sulfated steroids using liquid chromatography-mass spectrometry ∗ Laurie De Wilde , Kris Roels, Pieter Van Renterghem, Peter Van Eenoo, Koen Deventer 1 Doping Control Laboratory (DoCoLab), Ghent University (UGent), Department Diagnostic Sciences, Technologiepark 30B, B-9052 Zwijnaarde, Belgium a r t i c l e i n f o a b s t r a c t Article history: Detection of endogenous anabolic androgenic steroids (EAAS) misuse is a major challenge in doping con- Received 26 November 2019 trol analysis. Currently, a number of endogenous steroids, which constitute the steroid profile, are quanti- Revised 6 May 2020 fied using gas chromatography (GC). With this methodology, only the sum of the free and glucuronidated Accepted 10 May 2020 steroids is measured together. A dilute-and-shoot LC-MS method, which is compliant with the quality Available online 23 May 2020 requirements for measuring EAAS established by the World Anti-Doping Agency (WADA), was devel- Keywords: oped and validated containing glucuronidated and sulfated steroids in order to gain some extra infor- Doping mation and to expand the existing steroid profile. The developed method is, to the best of our knowl- Urine edge, the first method to combine both steroid glucuronides and sulfates, which is compliant with the Steroid profile quality standards of the technical document on EAAS, established by WADA.
    [Show full text]
  • Degradation and Metabolite Formation of Estrogen Conjugates in an Agricultural Soil
    Journal of Pharmaceutical and Biomedical Analysis 145 (2017) 634–640 Contents lists available at ScienceDirect Journal of Pharmaceutical and Biomedical Analysis j ournal homepage: www.elsevier.com/locate/jpba Degradation and metabolite formation of estrogen conjugates in an agricultural soil a,b b,∗ Li Ma , Scott R. Yates a Department of Environmental Sciences, University of California, Riverside, CA 92521, United States b Contaminant Fate and Transport Unit, U.S. Salinity Laboratory, Agricultural Research Service, United States Department of Agriculture, Riverside, CA 92507, United States a r t i c l e i n f o a b s t r a c t Article history: Estrogen conjugates are precursors of free estrogens such as 17ß-estradiol (E2) and estrone (E1), which Received 10 April 2017 cause potent endocrine disrupting effects on aquatic organisms. In this study, microcosm laboratory Received in revised form 11 July 2017 ◦ experiments were conducted at 25 C in an agricultural soil to investigate the aerobic degradation and Accepted 31 July 2017 metabolite formation kinetics of 17ß-estradiol-3-glucuronide (E2-3G) and 17ß-estradiol-3-sulfate (E2- Available online 1 August 2017 3S). The aerobic degradation of E2-3G and E2-3S followed first-order kinetics and the degradation rates were inversely related to their initial concentrations. The degradation of E2-3G and E2-3S was extraordi- Keywords: narily rapid with half of mass lost within hours. Considerable quantities of E2-3G (7.68 ng/g) and E2-3S Aerobic degradation 17ß-estradiol-3-glucuronide (4.84 ng/g) were detected at the end of the 20-d experiment, particularly for high initial concentrations.
    [Show full text]
  • Center for Studies in Demography and Ecology
    Page 1 K.A. O’Connor Center for Studies in Demography and Ecology Urinary enzyme-immunoassays for population research on reproduction: Estrone conjugates and pregnanediol-3-gluceronide by Kathleen O’Connor University of Washington UNIVERSITY OF WASHINGTON CSDE Working Paper No. 01-11 Page 2 K.A. O’Connor Title: Urinary enzyme-immunoassays for population research on reproduction: Estrone conjugates and pregnanediol-3-glucuronide. Running Title: Urinary EIA’s for population research: E1C and PDG Authors and Institutions: Kathleen A. O’Connor1 Eleanor Brindle1 Darryl J. Holman1 Nancy A. Klein 2 Michael R. Soules 2 Kenneth L. Campbell 3 Fortüne Kohen 4 Coralie J. Munro 5 William L. Lasley 6 James W. Wood 7 1 Department of Anthropology and Center for Studies in Demography and Ecology, University of Washington, Seattle WA 98195 2 Department of Obstetrics and Gynecology, University of Washington, Seattle WA 98195 3 Department of Biology, University of Massachusetts, Boston MA 02125 4 Department of Biological Regulation, Weizmann Institute of Science, Rehovet 76100 Israel 5 Department of Population Health and Reproduction, University of California, Davis, CA 95616 6 Department of Obstetrics and Gynecology, University of California, Davis, CA 95616 7 Department of Anthropology and Population Research Institute, Pennsylvania State University, University Park, PA 16802 Total Number of Pages:22 Number of Figures: 9 Number of Tables: 5 Keywords: E1G, E1C, EIA, PDG, urinary reproductive steroids, Quidel 330, validations, Bangladesh, 3F11 clone, 155B3 clone, assay validation, urine specimen stability, specific gravity Corresponding Author: Kathleen A. O’Connor Department of Anthropology Box 353100 University of Washington Seattle, Washington 98195 phone: (206) 543-9605 fax: (206) 543-3285 email: [email protected] Date: 10/19/2002 Page 3 K.A.
    [Show full text]
  • Development and Application of Methods for Extraction and LC/MS/MS Analysis of Sex Steroids and Conjugates from Fish Feces
    Development and Application of Methods for Extraction and LC/MS/MS Analysis of Sex Steroids and Conjugates from Fish Feces By Lisa E. Peters A Thesis submitted to the Faculty of Graduate Studies of The University of Manitoba in partial fulfilment of the requirements of the degree of Doctor of Philosophy Department of Environment and Geography University of Manitoba Winnipeg Copyright © 2014 Lisa E. Peters 1 Acknowledgments I would like to start by thanking my supervisor, Dr. Gregg Tomy, for his support, patience and resources during my Ph.D. program. He took a chance when I tried to convince him that my biology background would be a great addition to his chemistry lab. My husband, Vince Palace, and I also appreciated his support and genuine happiness for us when I announced we were expecting a baby in the middle of my studies. A sincere thanks also goes to my co-supervisor, Dr. Mark Hanson, for his support on so many levels (I wouldn’t even know where to start), and for doing his best to keep me on track, which was no small task. I would also like to thank my other thesis committee members, Drs. Gary Anderson and Feiyue Wang, for their encouragement and insightful comments. Gary gave a lot of extra time to review various thesis chapters and data, and to lend his expertise during the fish surgeries. I also had the pleasure of taking his Endocrinology course, which was probably the most informative and enjoyable class of my entire university student career. I would like to thank the technical staff and students from DFO, Suzanne Mittermuller, Kerry Wautier, Alea Goodmanson, Danielle Godard, Lisa Friedrich and Kirstin Dangerfield, and my lab mates Bruno Rosenberg, Kerri Pleskach, Colin Darling, Bonnie Gemmill and Lianna Bestvater for their technical input and help during my experiments.
    [Show full text]
  • Neurosteroids in Depression: a Review 39
    PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/71267 Please be advised that this information was generated on 2021-09-26 and may be subject to change. Frank van Broekhoven Effects of progesterone and allopregnanolone on stress, attention, cognition and mood | Frank van Broekhoven ISBN 978-90-9023655-1 Copyright ©2008 Frank van Broekhoven. The copyright of articles that have already been published has been transferred to the respective journals. No part of this book may be reproduced, in any form, without prior written permission from the author. Niets uit deze uitgave mag worden verveelvoudigd en/of openbaar gemaakt in welke vorm dan ook, zonder voorafgaande schriftelijke toestemming van de auteur. Coverdesign and layout by: Communicatie Kant, Dinxperlo, The Netherlands Printed by: Up2data, Bocholt, Germany The financial support for the printing of this thesis by Eli Lilly Nederland BV, Janssen-Cilag BV, the Department of Psychiatry from the Radboud University Nijmegen Medical Centre, and Karakter, Child and Adolescent Psy- chiatry University Centre, Nijmegen, is gratefully acknowledged. Effects of progesterone and allopregnanolone on stress, attention, cognition and mood Een wetenschappelijke proeve op het gebied van de Medische Wetenschappen Proefschrift ter verkrijging van de graad van doctor aan de Radboud Universiteit Nijmegen op gezag van de rector magnificus prof. mr. S.C.J.J. Kortmann, volgens besluit van het College van Decanen in het openbaar te verdedigen op maandag 24 november 2008 om 15.30 uur precies door Frank van Broekhoven geboren op 8 december 1969 te Groenlo Promotores: prof.
    [Show full text]
  • Testosterone, DHP, Progesterone, Es
    UC Davis Clinical Endocrinology Laboratory Volume Required: Testosterone: 2 mL serum AMH equine: 1 ml serum Estrone Sulfate, Progesterone: 1 mL serum each. Inhibin: 1 ml serum, sent overnight on ice. AMH Canine/Feline Spaychek: 200 µL serum, fasted, 30 days post- surgery. Send 0.5 ml for Progesterone/AMH and 2 ml for testosterone/AMH. Cryptorchid Panel: 2 mL serum Pregnancy Panel: 2 mL serum Granulosa Cell Tumor Panel: 3 mL serum Sample Handling and Shipment Requirements: PLEASE SEND SERUM ONLY, no whole or clotted blood. Blood contains active enzymes which may affect the results. The use of serum separator tubes is not recommended; they may degrade the analytes, particularly progesterone and AMH, and may invalidate results. Draw in a tube with no additive (red top). If you do use a serum separator tube, transfer the serum to a new tube as soon as possible. For AMH and inhibin testing: Please separate the serum and ship priority overnight on an ice pack. Store the sample in the freezer if shipping will be delayed, but you may ship it on an ice pack, dry ice is not required. Do not ship the sample via the US Postal Service, as the delivery will be delayed in the campus mailroom for up to a week, causing sample degradation. Do not ship the samples to arrive on a holiday or a weekend, as UPS and Fed Ex will not deliver it to us, and it will sit at the shipping facility, causing sample degradation. Please check our site for university holidays. For steroid hormone (testosterone, DHP, progesterone, estrone) testing: These hormones are more stable; however, they may be degraded by poor handling conditions, and shipment as whole or clotted blood.
    [Show full text]
  • The Structural Biology of Oestrogen Metabolism
    Journal of Steroid Biochemistry & Molecular Biology 137 (2013) 27–49 Contents lists available at ScienceDirect Journal of Steroid Biochemistry and Molecular Biology jo urnal homepage: www.elsevier.com/locate/jsbmb Review The structural biology of oestrogen metabolism ∗ Mark P. Thomas, Barry V.L. Potter Department of Pharmacy & Pharmacology, University of Bath, Claverton Down, Bath, BA2 7AY, UK a r t i c l e i n f o a b s t r a c t Article history: Many enzymes catalyse reactions that have an oestrogen as a substrate and/or a product. The reac- Received 11 September 2012 tions catalysed include aromatisation, oxidation, reduction, sulfonation, desulfonation, hydroxylation Received in revised form and methoxylation. The enzymes that catalyse these reactions must all recognise and bind oestrogen but, 10 December 2012 despite this, they have diverse structures. This review looks at each of these enzymes in turn, describing Accepted 12 December 2012 the structure and discussing the mechanism of the catalysed reaction. Since oestrogen has a role in many disease states inhibition of the enzymes of oestrogen metabolism may have an impact on the state or Keywords: progression of the disease and inhibitors of these enzymes are briefly discussed. Oestrogen This article is part of a Special Issue entitled ‘CSR 2013’. Protein structure © 2012 Elsevier Ltd. Open access under CC BY license. Reaction mechanism Aromatase Sulfatase Sulfotransferase 17␤-Hydroxysteroid dehydrogenase Contents 1. Introduction . 27 2. Methods . 29 3. Oestrogen sulfotransferase . 29 4. Steroid sulfatase. 31 5. 17␤-Hydroxysteroid dehydrogenases . 33 6. Aromatase (cytochrome P450 19A1, oestrogen synthase) . 36 7. Enzymes of steroid hydroxylation .
    [Show full text]